CEMP

Cempra, Inc. News Headlines

$9.42
*  
0.15
1.57%
Get CEMP Alerts
*Delayed - data as of Jul. 24, 2014 13:31 ET  -  Find a broker to begin trading CEMP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CEMP Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cempra - Don't Throw The Baby Out With The Bathwater
5/6/2014 10:44:00 AM - Seeking Alpha

Is Cempra (CEMP) Ready to Breakout? - Tale of the Tape
5/1/2014 7:14:01 AM - Zacks.com

Commit To Purchase Cempra At $12.50, Earn 15.5% Annualized Using Options
2/25/2014 1:12:21 PM - BNK Invest

Cempra (CEMP) Jumps: Stock Adds 6.1% in Session - Tale of the Tape
2/21/2014 10:39:01 AM - Zacks.com

Antibiotic Companies To Cash In On In 2014
2/13/2014 8:30:00 AM - Seeking Alpha

Cempra: Safety Results Solidifying Market Position
2/12/2014 10:54:00 AM - Seeking Alpha

Do Away With The Pill-A-Day Biotech Model: Steve Brozak
2/7/2014 2:05:00 PM - Seeking Alpha

Cempra (CEMP) Falls: Stock Plunges 10.7% - Tale of the Tape
1/28/2014 9:47:01 AM - Zacks.com

Pipeline Progress at Cempra - Analyst Blog
12/18/2013 7:00:01 PM - Zacks.com

Data on Oncothyreon's ONT-380 - Analyst Blog
10/8/2013 4:27:12 PM - Zacks.com

KYTHERA Proposes Public Offering - Analyst Blog
10/8/2013 3:27:55 PM - Zacks.com

Good News for Apricus from Germany - Analyst Blog
10/8/2013 2:28:11 PM - Zacks.com

Valeant's Jublia Approved in Canada - Analyst Blog
10/7/2013 3:25:01 PM - Zacks.com

Good News for Valeant - Analyst Blog
10/4/2013 11:50:01 AM - Zacks.com

Data on ArQule's Tivantinib - Analyst Blog
10/4/2013 11:06:39 AM - Zacks.com

Label Expansion for Roche's Perjeta - Analyst Blog
10/2/2013 1:50:08 PM - Zacks.com

Cempra (CEMP) Worth a Look: Stock Up 6.1% - Analyst Blog
10/1/2013 8:41:50 AM - Zacks.com

Update on Amarin Study - Analyst Blog
9/26/2013 5:32:59 PM - Zacks.com

Can the Rally in Cempra Inc. (CEMP) Shares Continue? - Tale of the Tape
9/24/2013 7:53:18 AM - Zacks.com

Data on Cempra's Solithromycin - Analyst Blog
9/6/2013 4:51:17 PM - Zacks.com

Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
6/25/2013 8:01:00 AM - Seeking Alpha

Can Cempra Beat The Superbugs?
6/17/2013 2:37:00 PM - Seeking Alpha

Cempra/Toyama Ink Deal - Analyst Blog
5/15/2013 5:29:32 PM - Zacks.com

Companies That Can Mend The Biotech Market: Stephen Brozak
4/12/2013 5:40:00 PM - Seeking Alpha

AMAG Narrows Loss, Maintains View - Analyst Blog
3/4/2013 2:39:01 PM - Zacks.com